title: Interleukin-22 inhibits tazarotene-induced gene 3 expression in HaCaT cells via MAPK-ERK1/2 and JAK2/STAT3 signaling.
authors.affiliation: Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, PR China.
authors.forename: Suju
authors.initials: S
authors.lastname: Luo
authors.affiliation: Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, PR China.
authors.forename: Xinxin
authors.initials: X
authors.lastname: Liu
authors.affiliation: Department of Dermatology, Second Hospital of Xi'an Jiaotong University, Xi'an 710004, Shanxi, PR China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Zheng
authors.affiliation: Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, PR China.
authors.forename: Yuan
authors.initials: Y
authors.lastname: Liu
authors.affiliation: Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, PR China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.affiliation: Department of Dermatology, Second Hospital of Xi'an Jiaotong University, Xi'an 710004, Shanxi, PR China.
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.affiliation: Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, PR China. Electronic address: 18222235016@163.com.
authors.forename: Haiyang
authors.initials: H
authors.lastname: Ni
authors.affiliation: Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, PR China. Electronic address: quanzhongliu2008@163.com.
authors.forename: Quanzhong
authors.initials: Q
authors.lastname: Liu
mesh_terms: D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation; D006801:Humans; D007378:Interleukins / Q000494:pharmacology*; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015603:Keratinocytes / Q000187:drug effects* / Q000201:enzymology; D019950:Mitogen-Activated Protein Kinase 1 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D018168:Receptors, Retinoic Acid / Q000235:genetics / Q000378:metabolism*; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D000097043:Interleukin-22
chemical_list: D007378:Interleukins; D053614:Janus Kinase 2; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D047428:Protein Kinase Inhibitors; D018168:Receptors, Retinoic Acid; D050796:STAT3 Transcription Factor; D000097043:Interleukin-22; C437968:PLAAT4 protein, human; C494086:STAT3 protein, human; C507924:JAK2 protein, human; C535150:MAPK1 protein, human